SCHICKWANN TSAI, M.D.
Osteopathic Medicine at Medical Dr, Salt Lake City, UT
License number
Utah 4981600-1205
Category
Osteopathic Medicine
Type
Internal Medicine
License number
Utah 4981600-1205
Category
Osteopathic Medicine
Type
Hematology & Oncology
Address
Address
50 N Medical Dr, Salt Lake City, UT 84132
Phone
(801) 581-2121
Personal information
See more information about SCHICKWANN TSAI at radaris.comName
Address
Phone
7978 Stauning Cv, Salt Lake Cty, UT 84121
7978 Stauning Cv, Salt Lake City, UT 84121
Organization information
See more information about SCHICKWANN TSAI at bizstanding.comSchickwann Tsai MD,PHD
1950 Cir Of Hope Dr, Salt Lake City, UT 84112
Industry:
Oncology, Internist
Phone:
(801) 587-7000 (Phone)
Description:
There are 11 doctors at this site. Surgery is not performed at this site.
Schickwann Tsai
Professional information
Dr. Schickwann Tsai - MD (Doctor of Medicine)
Hospitals:
30 N 1900 E, Salt Lake City 84132
50 N Medical Dr, Salt Lake City 84132
University of Utah Health Care
50 North Medical Dr, Salt Lake City 84132
30 N 1900 E, Salt Lake City 84132
50 N Medical Dr, Salt Lake City 84132
University of Utah Health Care
50 North Medical Dr, Salt Lake City 84132
50 N Medical Dr, Salt Lake City 84132
University of Utah Health Care
50 North Medical Dr, Salt Lake City 84132
30 N 1900 E, Salt Lake City 84132
50 N Medical Dr, Salt Lake City 84132
University of Utah Health Care
50 North Medical Dr, Salt Lake City 84132
Development Of Natural Killer Cells And Functional Natural Killer Cell Lines
US Patent:
2007004, Mar 1, 2007
Filed:
Aug 31, 2005
Appl. No.:
11/216837
Inventors:
Schickwann Tsai - Salt Lake City UT, US
International Classification:
A61K 35/14, C12N 5/08
US Classification:
424093700, 435372000
Abstract:
The invention relates to natural killer cells and methods for the development of immortalized natural killer cells and use of the natural killer cells. A growth and culture system is described that supports increased natural killer cell development, and provides for the establishment of continuous natural killer cell lines. Additionally, the disclosed method for generating natural killer cells may be used to produce large numbers of natural killer cells for therapeutic applications and for natural killer cell research.
Penumbra Nucleic Acid Molecules, Proteins And Uses Thereof
US Patent:
2009026, Oct 22, 2009
Filed:
Sep 28, 2006
Appl. No.:
11/992872
Inventors:
Schickwann Tsai - Salt Lake City UT, US
Zhong Chen - Sandy UT, US
Zhong Chen - Sandy UT, US
Assignee:
University of Utah Research Foundation - Salt Lake City UT
International Classification:
A61K 38/16, C07K 14/705, C12Q 1/68
US Classification:
514 12, 536 235, 435 6
Abstract:
The present invention relates to murine and human Penumbra (for proerythroblast nu[new] Membrane) nucleic acid molecules, proteins and the uses thereof. The invention further relates to the use of Penumbra molecules for the detection of 7q31q32-related deletions, including such deletions associated with myeloid malignancies, particularly detection by hybridization using Penumbra-based probes.